IMiD Sequencing in Relapsed Multiple Myeloma with Paul G. Richardson, MD
Case Scenario 1:
July 2011
August 2016
Bridging and BCMA Exposure Impact Ide-Cel Outcomes in Multiple Myeloma
June 9th 2025During a live event, Samuel M. Rubinstein, MD, discussed the outcomes from the KarMMa-3 trial and real-world patients receiving ide-cel in terms of bridging therapy, quality of life, and prior BCMA therapy.
Read More